ENDRA Life Sciences Inc. Common Stock (NDRA) Stock Price

NDRAStock

$4.74−32.29%52W

Market Cap$7.11M

P/E—

PEG Ratio—

Div yield—

Beta-0.16

NDRA Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-14.34%

Price vs S&P 500 (4W)-23.56%

VGM Score39.49

Book Value / Share (Quarterly)$4.21

P/TBV (Annual)21.12x

Indicated Dividend (Annual)$0.00

Cash Flow / Share (Quarterly)$-5.23

Price vs S&P 500 (YTD)-7.29%

Gross Margin (TTM)51.35%

Net Profit Margin (TTM)-2016.22%

EPS (TTM)$-5.98

10-Day Avg Trading Volume0.01M

EPS Excl Extra (TTM)$-5.98

EPS (Annual)$-8.93

ROI (Annual)-310.93%

Gross Margin (Annual)100.00%

Net Profit Margin (5Y Avg)-20124.55%

Cash / Share (Quarterly)$1.16

ROA (Last FY)-182.35%

EBITD / Share (TTM)$-4.77

ROE (5Y Avg)-245.08%

Operating Margin (TTM)-1921.62%

Cash Flow / Share (Annual)$-6.97

P/B Ratio1.13x

P/B Ratio (Quarterly)1.80x

Net Income / Employee (Annual)$-638,900

EV / Revenue (TTM)14.51x

Net Interest Coverage (TTM)-50.00x

ROA (TTM)-137.61%

EPS Incl Extra (Annual)$-8.93

Current Ratio (Annual)1.29x

Quick Ratio (Quarterly)7.04x

3-Month Avg Trading Volume0.04M

52-Week Price Return-32.29%

Revenue / Employee (TTM)$0

Tangible BV / Share (Quarterly)$0.21

P/S Ratio (Annual)710.92x

Asset Turnover (Annual)0.00x

52-Week High$7.55

Operating Margin (5Y Avg)-18450.33%

EPS Excl Extra (Annual)$-8.93

CapEx CAGR (5Y)106.68%

Tangible BV CAGR (5Y)6.43%

26-Week Price Return-4.44%

Quick Ratio (Annual)1.02x

13-Week Price Return-5.01%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)7.10x

Enterprise Value$5.37M

Asset Turnover (TTM)0.06x

Book Value / Share Growth (5Y)-14.53%

Revenue / Employee (Annual)$0

Inventory Turnover (Annual)0.00x

Pretax Margin (Annual)-98000.00%

Cash / Share (Annual)$0.65

3-Month Return Std Dev94.48%

Gross Margin (5Y Avg)62.27%

Net Income / Employee (TTM)$-537,900

ROE (Last FY)-310.93%

EPS Basic Excl Extra (Annual)$-8.93

Receivables Turnover (TTM)2.00x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-5.98

ROI (TTM)-224.80%

P/S Ratio (TTM)19.21x

Pretax Margin (5Y Avg)-20124.55%

Revenue / Share (Annual)$0.00

Tangible BV / Share (Annual)$0.21

Price vs S&P 500 (52W)-47.82%

Year-to-Date Return4.64%

5-Day Price Return-7.69%

EPS Normalized (Annual)$-8.93

ROA (5Y Avg)-163.84%

Net Profit Margin (Annual)-98000.00%

Month-to-Date Return-20.47%

Cash Flow / Share (TTM)$-2.35

EBITD / Share (Annual)$-7.27

Operating Margin (Annual)-90200.00%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-244.69%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-5.98

P/TBV (Quarterly)21.12x

P/B Ratio (Annual)2.34x

Inventory Turnover (TTM)0.00x

Pretax Margin (TTM)-2016.22%

Book Value / Share (Annual)$1.92

Price vs S&P 500 (13W)-7.70%

Beta-0.16x

Revenue / Share (TTM)$0.00

ROE (TTM)-224.80%

52-Week Low$2.96

vGradeD

mGradeC

vgmGradeD

NDRA Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 14, 2026	-$0.84	-$1.17	-39.37%(-$0.33)
Q1 2026	May 15, 2026	-$1.23	-$1.09	+11.38%(+$0.14)
Q4 2025	Mar 31, 2026	-$1.23	-$2.23	-81.68%(-$1.00)
Q3 2025	Nov 14, 2025	-$1.95	-$2.10	-7.69%(-$0.15)
Q2 2025	Aug 14, 2025	-$2.27	-$1.71	+24.67%(+$0.56)

NDRA Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.14

Industry Peers — Electromedical Equipment(31)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth (5Y)	Gross Margin (TTM)	Operating Margin (TTM)	Price
NDRAENDRA Life Sciences Inc. Common Stock	D	—	C	19.2x	—	51.4%	-1921.6%	$4.74
MDTMedtronic plc	B	C	B	3.2x	3.8%	65.7%	18.1%	$94.75
ITGRInteger Holdings Corporation	C	C	A	2.3x	11.6%	26.1%	9.7%	$126.70
LIVNLivaNova PLC Ordinary Shares	C	B	B	2.9x	8.2%	68.1%	12.5%	$77.58
TMDXTransMedics Group, Inc. Common Stock	C	B	D	3.7x	88.2%	58.7%	12.2%	$70.78
AXGNAxogen, Inc. Common Stock	F	B	B	8.1x	14.9%	74.6%	-11.8%	$34.62
BLFSBioLife Solutions Inc.	F	C	A	18.4x	14.9%	63.9%	2.9%	$38.61
CNMDCONMED Corporation	B	C	B	1.0x	9.8%	55.8%	8.0%	$46.72
CBLLCeriBell, Inc. Common Stock	F	A	A	9.4x	—	88.9%	-68.6%	$25.04
INMDInMode Ltd. Ordinary Shares	A	D	C	2.2x	12.4%	76.5%	18.5%	$14.16
CVCapsoVision, Inc. Common Stock	F	D	B	25.0x	—	50.9%	-217.1%	$6.53
ELMDElectromed, Inc.	C	B	C	3.1x	15.6%	78.5%	18.8%	$27.42
FOCLEDAP TMS S.A. American Depositary Shares	C	C	D	2.3x	9.4%	47.6%	-40.7%	$4.09
STXSStereotaxis, Inc. Common Stock	D	F	D	3.4x	4.0%	55.6%	-75.7%	$1.01
VANIVivani Medical, Inc. Common Stock (DE)	—	—	C	29.9x	—	36.4%	-1004.7%	$1.12
NRXSNeuraxis, Inc.	F	A	A	18.2x	13.1%	85.5%	-144.5%	$7.70
STEXStreamex Corp. Common Stock	—	C	F	298.3x	—	100.0%	-10384.3%	$0.37
HYPRHyperfine, Inc. Class A Common Stock	C	A	D	4.8x	115.2%	51.4%	-203.3%	$0.75
OMOutset Medical, Inc. Common Stock	A	C	C	0.6x	19.1%	41.8%	-56.1%	$3.94
ECORelectroCore, Inc. Common Stock	C	A	B	1.9x	55.7%	87.5%	-37.6%	$7.85
POCIPrecision Optics Corporation, Inc. Common Stock	C	A	C	1.5x	24.2%	17.2%	-11.1%	$4.32
QTIQT Imaging Holdings, Inc. Common Stock	C	A	D	1.3x	—	40.4%	-56.2%	$2.40
ITOCiTonic Holdings Ltd Class A Ordinary Shares	—	A	C	50.5x	—	60.9%	-1776.4%	$3.84
IRIXIridex Corp	B	D	D	0.3x	7.7%	35.9%	-5.4%	$0.81
NXLNexalin Technology, Inc. Common Stock	D	D	F	11.3x	4.4%	86.2%	-4202.4%	$2.35
NUWENuwellis, Inc. Common Stock	—	D	F	0.2x	2.1%	69.7%	-142.9%	$0.55
EDAPEDAP TMS SA	D	C	C	2.2x	9.4%	46.6%	-37.3%	$3.99
EYESCorgi Data & Surveillance ETF	—	C	C	—	—	—	—	$28.78
FONRFonar Corporation	B	D	B	1.3x	4.0%	40.3%	9.1%	$0.00
MASIMasimo Corporation	D	D	B	6.0x	6.0%	61.7%	19.9%	$0.00
QSIAWQuantum-Si Incorporated Warrant	—	—	F	—	—	—	—	$0.00
TIVCTivic Health Systems, Inc. Common Stock	—	B	F	8.4x	13.2%	-58.1%	-1549.0%	$2.49

About ENDRA Life Sciences Inc. Common Stock

ENDRA Life Sciences develops Thermo Acoustic Enhanced Ultrasound (TAEUS), a point-of-care imaging technology that delivers MRI-quality tissue visualization at ultrasound cost using existing ultrasound systems globally. The company is initially targeting assessment of fatty liver disease (NAFLD/NASH), which affects over 1 billion people worldwide with no practical diagnostic tools currently available. Additional applications include thermal imaging during energy-based surgical procedures.